Instrument Inactif

Autres langues Metabolix, Inc. Nasdaq

Actions

US5910188094

Recherche biotechnologique et médicale

Autres langues

31/10/25	Yield10 Bioscience, Inc. Went Out of Business
14/10/25	First Amended Joint Liquidation Plan Approved for Yield10 Bioscience, Inc.
20/08/25	First Amended Disclosure Statement Approved for Yield10 Bioscience, Inc.
18/08/25	First Amended Joint Liquidation Plan and Disclosure Statement Filed by Yield10 Bioscience, Inc.
10/07/25	Joint Liquidation Plan and Disclosure Statement Filed by Yield10 Bioscience, Inc.
08/01/25	Motion for Asset Sale Approved for Yield10 Bioscience, Inc.
10/12/24	Motion for Joint Administration Approved for Yield10 Bioscience, Inc.
06/12/24	Yield10 Approves Wind Down of Operations and Corresponding Reduction in Workforce
06/12/24	Yield10 Bioscience, Inc. Announces Board Changes
06/12/24	Motion for Asset Sale Filed by Yield10 Bioscience, Inc.
06/12/24	Yield10 Bioscience, Inc. Filed for Bankruptcy
06/12/24	Motion for Joint Administration Filed by Yield10 Bioscience, Inc.
12/11/24	Yield10 Bioscience : Announces Adjournment of Special Meeting of Stockholders to Solicit Sufficient Votes in Favor of the Key Proposals; Special Meeting Adjourned to Thursday, November 14, 2024 Form 8 K
12/11/24	Yield10 Bioscience, Inc. announced that it has received $3 million in funding
31/10/24	Kristi D. Snell, Ph.D., Resigns as Vice President Research and Chief Science Officer of Yield10 Bioscience, Inc
03/10/24	Nuseed Nutritional US Inc. entered into an asset purchase agreement to acquire Substantially all assets of Yield10 Bioscience, Inc./Yield10 Oilseeds, Inc. from Yield10 Bioscience, Inc. and Yield10 Oilseeds, Inc. for $5 million.
05/09/24	Yield10 Bioscience, Inc. announced that it expects to receive $3 million in funding
14/08/24	Yield10 Bioscience Announces Second Quarter 2024 Financial Results
14/08/24	Yield10 Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
18/07/24	Nufarm Secures License to Yield10's Omega-3 Assets
17/07/24	Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets
17/07/24	Yield10 Bioscience Grants Nufarm A Commercial License to Omega-3 Assets for Producing Oil in Camelina
17/06/24	Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina
17/06/24	Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina
12/06/24	Yield10 Bioscience : Certificate of Incorporation/Bylaws Form 8 K